ID   AAPK1_HUMAN             Reviewed;         559 AA.
AC   Q13131; A8MTQ6; B2R7E1; O00286; Q5D0E1; Q86VS1; Q9UNQ4;
DT   15-JUL-1998, integrated into UniProtKB/Swiss-Prot.
DT   28-JUL-2009, sequence version 4.
DT   10-MAY-2017, entry version 187.
DE   RecName: Full=5'-AMP-activated protein kinase catalytic subunit alpha-1;
DE            Short=AMPK subunit alpha-1;
DE            EC=2.7.11.1 {ECO:0000250|UniProtKB:P54645};
DE   AltName: Full=Acetyl-CoA carboxylase kinase;
DE            Short=ACACA kinase;
DE            EC=2.7.11.27 {ECO:0000250|UniProtKB:P54645};
DE   AltName: Full=Hydroxymethylglutaryl-CoA reductase kinase;
DE            Short=HMGCR kinase;
DE            EC=2.7.11.31 {ECO:0000250|UniProtKB:P54645};
DE   AltName: Full=Tau-protein kinase PRKAA1;
DE            EC=2.7.11.26;
GN   Name=PRKAA1; Synonyms=AMPK1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Primates; Haplorrhini;
OC   Catarrhini; Hominidae; Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15372022; DOI=10.1038/nature02919;
RA   Schmutz J., Martin J., Terry A., Couronne O., Grimwood J., Lowry S.,
RA   Gordon L.A., Scott D., Xie G., Huang W., Hellsten U., Tran-Gyamfi M.,
RA   She X., Prabhakar S., Aerts A., Altherr M., Bajorek E., Black S.,
RA   Branscomb E., Caoile C., Challacombe J.F., Chan Y.M., Denys M.,
RA   Detter J.C., Escobar J., Flowers D., Fotopulos D., Glavina T.,
RA   Gomez M., Gonzales E., Goodstein D., Grigoriev I., Groza M.,
RA   Hammon N., Hawkins T., Haydu L., Israni S., Jett J., Kadner K.,
RA   Kimball H., Kobayashi A., Lopez F., Lou Y., Martinez D., Medina C.,
RA   Morgan J., Nandkeshwar R., Noonan J.P., Pitluck S., Pollard M.,
RA   Predki P., Priest J., Ramirez L., Retterer J., Rodriguez A.,
RA   Rogers S., Salamov A., Salazar A., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wheeler J., Wu K., Yang J., Dickson M.,
RA   Cheng J.-F., Eichler E.E., Olsen A., Pennacchio L.A., Rokhsar D.S.,
RA   Richardson P., Lucas S.M., Myers R.M., Rubin E.M.;
RT   "The DNA sequence and comparative analysis of human chromosome 5.";
RL   Nature 431:268-274(2004).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2), AND VARIANT
RP   LEU-10.
RC   TISSUE=Brain, and Testis;
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA
RT   project: the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 3-559 (ISOFORM 1).
RC   TISSUE=Mammary gland;
RA   Yano K.;
RT   "Nucleotide sequence of cDNA for human AMP-activated protein kinase
RT   alpha-1.";
RL   Submitted (JAN-1999) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 5-559 (ISOFORM 1).
RC   TISSUE=Trachea;
RX   PubMed=14702039; DOI=10.1038/ng1285;
RA   Ota T., Suzuki Y., Nishikawa T., Otsuki T., Sugiyama T., Irie R.,
RA   Wakamatsu A., Hayashi K., Sato H., Nagai K., Kimura K., Makita H.,
RA   Sekine M., Obayashi M., Nishi T., Shibahara T., Tanaka T., Ishii S.,
RA   Yamamoto J., Saito K., Kawai Y., Isono Y., Nakamura Y., Nagahari K.,
RA   Murakami K., Yasuda T., Iwayanagi T., Wagatsuma M., Shiratori A.,
RA   Sudo H., Hosoiri T., Kaku Y., Kodaira H., Kondo H., Sugawara M.,
RA   Takahashi M., Kanda K., Yokoi T., Furuya T., Kikkawa E., Omura Y.,
RA   Abe K., Kamihara K., Katsuta N., Sato K., Tanikawa M., Yamazaki M.,
RA   Ninomiya K., Ishibashi T., Yamashita H., Murakawa K., Fujimori K.,
RA   Tanai H., Kimata M., Watanabe M., Hiraoka S., Chiba Y., Ishida S.,
RA   Ono Y., Takiguchi S., Watanabe S., Yosida M., Hotuta T., Kusano J.,
RA   Kanehori K., Takahashi-Fujii A., Hara H., Tanase T.-O., Nomura Y.,
RA   Togiya S., Komai F., Hara R., Takeuchi K., Arita M., Imose N.,
RA   Musashino K., Yuuki H., Oshima A., Sasaki N., Aotsuka S.,
RA   Yoshikawa Y., Matsunawa H., Ichihara T., Shiohata N., Sano S.,
RA   Moriya S., Momiyama H., Satoh N., Takami S., Terashima Y., Suzuki O.,
RA   Nakagawa S., Senoh A., Mizoguchi H., Goto Y., Shimizu F., Wakebe H.,
RA   Hishigaki H., Watanabe T., Sugiyama A., Takemoto M., Kawakami B.,
RA   Yamazaki M., Watanabe K., Kumagai A., Itakura S., Fukuzumi Y.,
RA   Fujimori Y., Komiyama M., Tashiro H., Tanigami A., Fujiwara T.,
RA   Ono T., Yamada K., Fujii Y., Ozaki K., Hirao M., Ohmori Y.,
RA   Kawabata A., Hikiji T., Kobatake N., Inagaki H., Ikema Y., Okamoto S.,
RA   Okitani R., Kawakami T., Noguchi S., Itoh T., Shigeta K., Senba T.,
RA   Matsumura K., Nakajima Y., Mizuno T., Morinaga M., Sasaki M.,
RA   Togashi T., Oyama M., Hata H., Watanabe M., Komatsu T.,
RA   Mizushima-Sugano J., Satoh T., Shirai Y., Takahashi Y., Nakagawa K.,
RA   Okumura K., Nagase T., Nomura N., Kikuchi H., Masuho Y., Yamashita R.,
RA   Nakai K., Yada T., Nakamura Y., Ohara O., Isogai T., Sugano S.;
RT   "Complete sequencing and characterization of 21,243 full-length human
RT   cDNAs.";
RL   Nat. Genet. 36:40-45(2004).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 9-559 (ISOFORM 1).
RC   TISSUE=Umbilical cord blood;
RX   PubMed=11042152; DOI=10.1101/gr.140200;
RA   Zhang Q.-H., Ye M., Wu X.-Y., Ren S.-X., Zhao M., Zhao C.-J., Fu G.,
RA   Shen Y., Fan H.-Y., Lu G., Zhong M., Xu X.-R., Han Z.-G., Zhang J.-W.,
RA   Tao J., Huang Q.-H., Zhou J., Hu G.-X., Gu J., Chen S.-J., Chen Z.;
RT   "Cloning and functional analysis of cDNAs with open reading frames for
RT   300 previously undefined genes expressed in CD34+ hematopoietic
RT   stem/progenitor cells.";
RL   Genome Res. 10:1546-1560(2000).
RN   [6]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 36-209 (ISOFORM 1).
RC   TISSUE=Intestine;
RA   Taboada E.N., Hickey D.A.;
RL   Submitted (APR-1995) to the EMBL/GenBank/DDBJ databases.
RN   [7]
RP   NUCLEOTIDE SEQUENCE [MRNA] OF 303-559 (ISOFORMS 1/2).
RC   TISSUE=Liver;
RX   PubMed=8557660; DOI=10.1074/jbc.271.2.611;
RA   Stapleton D., Mitchelhill K.I., Gao G., Widmer J., Michell B.J.,
RA   Teh T., House C.M., Fernandez C.S., Cox T., Witters L.A., Kemp B.E.;
RT   "Mammalian AMP-activated protein kinase subfamily.";
RL   J. Biol. Chem. 271:611-614(1996).
RN   [8]
RP   DOMAIN AIS.
RX   PubMed=9857077; DOI=10.1074/jbc.273.52.35347;
RA   Crute B.E., Seefeld K., Gamble J., Kemp B.E., Witters L.A.;
RT   "Functional domains of the alpha1 catalytic subunit of the AMP-
RT   activated protein kinase.";
RL   J. Biol. Chem. 273:35347-35354(1998).
RN   [9]
RP   FUNCTION.
RX   PubMed=11554766; DOI=10.1006/bbrc.2001.5627;
RA   Imamura K., Ogura T., Kishimoto A., Kaminishi M., Esumi H.;
RT   "Cell cycle regulation via p53 phosphorylation by a 5'-AMP activated
RT   protein kinase activator, 5-aminoimidazole-4-carboxamide-1-beta-D-
RT   ribofuranoside, in a human hepatocellular carcinoma cell line.";
RL   Biochem. Biophys. Res. Commun. 287:562-567(2001).
RN   [10]
RP   FUNCTION IN PHOSPHORYLATION OF EP300.
RX   PubMed=11518699; DOI=10.1074/jbc.C100316200;
RA   Yang W., Hong Y.H., Shen X.Q., Frankowski C., Camp H.S., Leff T.;
RT   "Regulation of transcription by AMP-activated protein kinase:
RT   phosphorylation of p300 blocks its interaction with nuclear
RT   receptors.";
RL   J. Biol. Chem. 276:38341-38344(2001).
RN   [11]
RP   ENZYME REGULATION.
RX   PubMed=11602624; DOI=10.1172/JCI13505;
RA   Zhou G., Myers R., Li Y., Chen Y., Shen X., Fenyk-Melody J., Wu M.,
RA   Ventre J., Doebber T., Fujii N., Musi N., Hirshman M.F.,
RA   Goodyear L.J., Moller D.E.;
RT   "Role of AMP-activated protein kinase in mechanism of metformin
RT   action.";
RL   J. Clin. Invest. 108:1167-1174(2001).
RN   [12]
RP   FUNCTION IN PHOSPHORYLATION OF CFTR.
RX   PubMed=12519745; DOI=10.1152/ajpcell.00227.2002;
RA   Hallows K.R., Kobinger G.P., Wilson J.M., Witters L.A., Foskett J.K.;
RT   "Physiological modulation of CFTR activity by AMP-activated protein
RT   kinase in polarized T84 cells.";
RL   Am. J. Physiol. 284:C1297-C1308(2003).
RN   [13]
RP   FUNCTION IN PHOSPHORYLATION OF TSC2.
RX   PubMed=14651849; DOI=10.1016/S0092-8674(03)00929-2;
RA   Inoki K., Zhu T., Guan K.L.;
RT   "TSC2 mediates cellular energy response to control cell growth and
RT   survival.";
RL   Cell 115:577-590(2003).
RN   [14]
RP   PHOSPHORYLATION AT THR-183, AND ENZYME REGULATION.
RX   PubMed=14976552; DOI=10.1038/sj.emboj.7600110;
RA   Lizcano J.M., Goeransson O., Toth R., Deak M., Morrice N.A.,
RA   Boudeau J., Hawley S.A., Udd L., Maekelae T.P., Hardie D.G.,
RA   Alessi D.R.;
RT   "LKB1 is a master kinase that activates 13 kinases of the AMPK
RT   subfamily, including MARK/PAR-1.";
RL   EMBO J. 23:833-843(2004).
RN   [15]
RP   PHOSPHORYLATION AT THR-183, AND ENZYME REGULATION.
RX   PubMed=16054095; DOI=10.1016/j.cmet.2005.05.009;
RA   Hawley S.A., Pan D.A., Mustard K.J., Ross L., Bain J., Edelman A.M.,
RA   Frenguelli B.G., Hardie D.G.;
RT   "Calmodulin-dependent protein kinase kinase-beta is an alternative
RT   upstream kinase for AMP-activated protein kinase.";
RL   Cell Metab. 2:9-19(2005).
RN   [16]
RP   PHOSPHORYLATION AT THR-183, AND ENZYME REGULATION.
RX   PubMed=15980064; DOI=10.1074/jbc.M503824200;
RA   Hurley R.L., Anderson K.A., Franzone J.M., Kemp B.E., Means A.R.,
RA   Witters L.A.;
RT   "The Ca2+/calmodulin-dependent protein kinase kinases are AMP-
RT   activated protein kinase kinases.";
RL   J. Biol. Chem. 280:29060-29066(2005).
RN   [17]
RP   FUNCTION, AND SUBCELLULAR LOCATION.
RX   PubMed=15866171; DOI=10.1016/j.molcel.2005.03.027;
RA   Jones R.G., Plas D.R., Kubek S., Buzzai M., Mu J., Xu Y.,
RA   Birnbaum M.J., Thompson C.B.;
RT   "AMP-activated protein kinase induces a p53-dependent metabolic
RT   checkpoint.";
RL   Mol. Cell 18:283-293(2005).
RN   [18]
RP   INTERACTION WITH FNIP1.
RX   PubMed=17028174; DOI=10.1073/pnas.0603781103;
RA   Baba M., Hong S.-B., Sharma N., Warren M.B., Nickerson M.L.,
RA   Iwamatsu A., Esposito D., Gillette W.K., Hopkins R.F. III,
RA   Hartley J.L., Furihata M., Oishi S., Zhen W., Burke T.R. Jr.,
RA   Linehan W.M., Schmidt L.S., Zbar B.;
RT   "Folliculin encoded by the BHD gene interacts with a binding protein,
RT   FNIP1, and AMPK, and is involved in AMPK and mTOR signaling.";
RL   Proc. Natl. Acad. Sci. U.S.A. 103:15552-15557(2006).
RN   [19]
RP   DOMAIN AIS, AND MUTAGENESIS OF VAL-307.
RX   PubMed=17088252; DOI=10.1074/jbc.M605790200;
RA   Pang T., Xiong B., Li J.Y., Qiu B.Y., Jin G.Z., Shen J.K., Li J.;
RT   "Conserved alpha-helix acts as autoinhibitory sequence in AMP-
RT   activated protein kinase alpha subunits.";
RL   J. Biol. Chem. 282:495-506(2007).
RN   [20]
RP   FUNCTION IN PHOSPHORYLATION OF FOXO3.
RX   PubMed=17711846; DOI=10.1074/jbc.M705325200;
RA   Greer E.L., Oskoui P.R., Banko M.R., Maniar J.M., Gygi M.P.,
RA   Gygi S.P., Brunet A.;
RT   "The energy sensor AMP-activated protein kinase directly regulates the
RT   mammalian FOXO3 transcription factor.";
RL   J. Biol. Chem. 282:30107-30119(2007).
RN   [21]
RP   FUNCTION IN CELL POLARITY.
RX   PubMed=17486097; DOI=10.1038/nature05828;
RA   Lee J.H., Koh H., Kim M., Kim Y., Lee S.Y., Karess R.E., Lee S.H.,
RA   Shong M., Kim J.M., Kim J., Chung J.;
RT   "Energy-dependent regulation of cell structure by AMP-activated
RT   protein kinase.";
RL   Nature 447:1017-1020(2007).
RN   [22]
RP   FUNCTION IN PHOSPHORYLATION OF HDAC5.
RX   PubMed=18184930; DOI=10.2337/db07-0843;
RA   McGee S.L., van Denderen B.J., Howlett K.F., Mollica J.,
RA   Schertzer J.D., Kemp B.E., Hargreaves M.;
RT   "AMP-activated protein kinase regulates GLUT4 transcription by
RT   phosphorylating histone deacetylase 5.";
RL   Diabetes 57:860-867(2008).
RN   [23]
RP   INTERACTION WITH FNIP2.
RX   PubMed=18403135; DOI=10.1016/j.gene.2008.02.022;
RA   Hasumi H., Baba M., Hong S.-B., Hasumi Y., Huang Y., Yao M.,
RA   Valera V.A., Linehan W.M., Schmidt L.S.;
RT   "Identification and characterization of a novel folliculin-interacting
RT   protein FNIP2.";
RL   Gene 415:60-67(2008).
RN   [24]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-382, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18220336; DOI=10.1021/pr0705441;
RA   Cantin G.T., Yi W., Lu B., Park S.K., Xu T., Lee J.-D.,
RA   Yates J.R. III;
RT   "Combining protein-based IMAC, peptide-based IMAC, and MudPIT for
RT   efficient phosphoproteomic analysis.";
RL   J. Proteome Res. 7:1346-1351(2008).
RN   [25]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Platelet;
RX   PubMed=18088087; DOI=10.1021/pr0704130;
RA   Zahedi R.P., Lewandrowski U., Wiesner J., Wortelkamp S., Moebius J.,
RA   Schuetz C., Walter U., Gambaryan S., Sickmann A.;
RT   "Phosphoproteome of resting human platelets.";
RL   J. Proteome Res. 7:526-534(2008).
RN   [26]
RP   FUNCTION IN PHOSPHORYLATION OF RPTOR.
RX   PubMed=18439900; DOI=10.1016/j.molcel.2008.03.003;
RA   Gwinn D.M., Shackelford D.B., Egan D.F., Mihaylova M.M., Mery A.,
RA   Vasquez D.S., Turk B.E., Shaw R.J.;
RT   "AMPK phosphorylation of raptor mediates a metabolic checkpoint.";
RL   Mol. Cell 30:214-226(2008).
RN   [27]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18691976; DOI=10.1016/j.molcel.2008.07.007;
RA   Daub H., Olsen J.V., Bairlein M., Gnad F., Oppermann F.S., Korner R.,
RA   Greff Z., Keri G., Stemmann O., Mann M.;
RT   "Kinase-selective enrichment enables quantitative phosphoproteomics of
RT   the kinome across the cell cycle.";
RL   Mol. Cell 31:438-448(2008).
RN   [28]
RP   INTERACTION WITH FNIP2.
RX   PubMed=18663353; DOI=10.1038/onc.2008.261;
RA   Takagi Y., Kobayashi T., Shiono M., Wang L., Piao X., Sun G.,
RA   Zhang D., Abe M., Hagiwara Y., Takahashi K., Hino O.;
RT   "Interaction of folliculin (Birt-Hogg-Dube gene product) with a novel
RT   Fnip1-like (FnipL/Fnip2) protein.";
RL   Oncogene 27:5339-5347(2008).
RN   [29]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT SER-356; SER-486; THR-490
RP   AND SER-496, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE
RP   ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=18669648; DOI=10.1073/pnas.0805139105;
RA   Dephoure N., Zhou C., Villen J., Beausoleil S.A., Bakalarski C.E.,
RA   Elledge S.J., Gygi S.P.;
RT   "A quantitative atlas of mitotic phosphorylation.";
RL   Proc. Natl. Acad. Sci. U.S.A. 105:10762-10767(2008).
RN   [30]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-32 AND SER-467, AND
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=19369195; DOI=10.1074/mcp.M800588-MCP200;
RA   Oppermann F.S., Gnad F., Olsen J.V., Hornberger R., Greff Z., Keri G.,
RA   Mann M., Daub H.;
RT   "Large-scale proteomics analysis of the human kinome.";
RL   Mol. Cell. Proteomics 8:1751-1764(2009).
RN   [31]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-382, AND IDENTIFICATION
RP   BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Leukemic T-cell;
RX   PubMed=19690332; DOI=10.1126/scisignal.2000007;
RA   Mayya V., Lundgren D.H., Hwang S.-I., Rezaul K., Wu L., Eng J.K.,
RA   Rodionov V., Han D.K.;
RT   "Quantitative phosphoproteomic analysis of T cell receptor signaling
RT   reveals system-wide modulation of protein-protein interactions.";
RL   Sci. Signal. 2:RA46-RA46(2009).
RN   [32]
RP   FUNCTION IN PHOSPHORYLATION OF KLC1.
RX   PubMed=20074060; DOI=10.1042/BST0380205;
RA   McDonald A., Fogarty S., Leclerc I., Hill E.V., Hardie D.G.,
RA   Rutter G.A.;
RT   "Cell-wide analysis of secretory granule dynamics in three dimensions
RT   in living pancreatic beta-cells: evidence against a role for AMPK-
RT   dependent phosphorylation of KLC1 at Ser517/Ser520 in glucose-
RT   stimulated insulin granule movement.";
RL   Biochem. Soc. Trans. 38:205-208(2010).
RN   [33]
RP   FUNCTION.
RX   PubMed=20160076; DOI=10.1073/pnas.0913860107;
RA   Alexander A., Cai S.L., Kim J., Nanez A., Sahin M., MacLean K.H.,
RA   Inoki K., Guan K.L., Shen J., Person M.D., Kusewitt D., Mills G.B.,
RA   Kastan M.B., Walker C.L.;
RT   "ATM signals to TSC2 in the cytoplasm to regulate mTORC1 in response
RT   to ROS.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:4153-4158(2010).
RN   [34]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma;
RX   PubMed=20068231; DOI=10.1126/scisignal.2000475;
RA   Olsen J.V., Vermeulen M., Santamaria A., Kumar C., Miller M.L.,
RA   Jensen L.J., Gnad F., Cox J., Jensen T.S., Nigg E.A., Brunak S.,
RA   Mann M.;
RT   "Quantitative phosphoproteomics reveals widespread full
RT   phosphorylation site occupancy during mitosis.";
RL   Sci. Signal. 3:RA3-RA3(2010).
RN   [35]
RP   PHOSPHORYLATION BY ULK1 AND ULK2.
RX   PubMed=21460634; DOI=10.4161/auto.7.7.15451;
RA   Loffler A.S., Alers S., Dieterle A.M., Keppeler H., Franz-Wachtel M.,
RA   Kundu M., Campbell D.G., Wesselborg S., Alessi D.R., Stork B.;
RT   "Ulk1-mediated phosphorylation of AMPK constitutes a negative
RT   regulatory feedback loop.";
RL   Autophagy 7:696-706(2011).
RN   [36]
RP   IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS].
RX   PubMed=21269460; DOI=10.1186/1752-0509-5-17;
RA   Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P.,
RA   Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J.;
RT   "Initial characterization of the human central proteome.";
RL   BMC Syst. Biol. 5:17-17(2011).
RN   [37]
RP   FUNCTION IN PHOSPHORYLATION OF ULK1.
RX   PubMed=21205641; DOI=10.1126/science.1196371;
RA   Egan D.F., Shackelford D.B., Mihaylova M.M., Gelino S., Kohnz R.A.,
RA   Mair W., Vasquez D.S., Joshi A., Gwinn D.M., Taylor R., Asara J.M.,
RA   Fitzpatrick J., Dillin A., Viollet B., Kundu M., Hansen M., Shaw R.J.;
RT   "Phosphorylation of ULK1 (hATG1) by AMP-activated protein kinase
RT   connects energy sensing to mitophagy.";
RL   Science 331:456-461(2011).
RN   [38]
RP   INTERACTION WITH PRKAB1 AND PRKAG1, AND ENZYME REGULATION.
RX   PubMed=21680840; DOI=10.1126/science.1200094;
RA   Oakhill J.S., Steel R., Chen Z.P., Scott J.W., Ling N., Tam S.,
RA   Kemp B.E.;
RT   "AMPK is a direct adenylate charge-regulated protein kinase.";
RL   Science 332:1433-1435(2011).
RN   [39]
RP   REVIEW ON FUNCTION.
RX   PubMed=17307971; DOI=10.1161/01.RES.0000256090.42690.05;
RA   Towler M.C., Hardie D.G.;
RT   "AMP-activated protein kinase in metabolic control and insulin
RT   signaling.";
RL   Circ. Res. 100:328-341(2007).
RN   [40]
RP   REVIEW ON FUNCTION.
RX   PubMed=17712357; DOI=10.1038/nrm2249;
RA   Hardie D.G.;
RT   "AMP-activated/SNF1 protein kinases: conserved guardians of cellular
RT   energy.";
RL   Nat. Rev. Mol. Cell Biol. 8:774-785(2007).
RN   [41]
RP   DEPHOSPHORYLATION.
RX   PubMed=23088624; DOI=10.1042/BJ20121201;
RA   Chida T., Ando M., Matsuki T., Masu Y., Nagaura Y.,
RA   Takano-Yamamoto T., Tamura S., Kobayashi T.;
RT   "N-Myristoylation is essential for protein phosphatases PPM1A and
RT   PPM1B to dephosphorylate their physiological substrates in cells.";
RL   Biochem. J. 449:741-749(2013).
RN   [42]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-32; THR-382; SER-486;
RP   THR-490 AND SER-496, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Cervix carcinoma, and Erythroleukemia;
RX   PubMed=23186163; DOI=10.1021/pr300630k;
RA   Zhou H., Di Palma S., Preisinger C., Peng M., Polat A.N., Heck A.J.,
RA   Mohammed S.;
RT   "Toward a comprehensive characterization of a human cancer cell
RT   phosphoproteome.";
RL   J. Proteome Res. 12:260-271(2013).
RN   [43]
RP   PHOSPHORYLATION [LARGE SCALE ANALYSIS] AT THR-355; SER-496; SER-508;
RP   SER-524 AND SER-527, AND IDENTIFICATION BY MASS SPECTROMETRY [LARGE
RP   SCALE ANALYSIS].
RC   TISSUE=Liver;
RX   PubMed=24275569; DOI=10.1016/j.jprot.2013.11.014;
RA   Bian Y., Song C., Cheng K., Dong M., Wang F., Huang J., Sun D.,
RA   Wang L., Ye M., Zou H.;
RT   "An enzyme assisted RP-RPLC approach for in-depth analysis of human
RT   liver phosphoproteome.";
RL   J. Proteomics 96:253-262(2014).
RN   [44]
RP   VARIANT [LARGE SCALE ANALYSIS] ARG-16.
RX   PubMed=16959974; DOI=10.1126/science.1133427;
RA   Sjoeblom T., Jones S., Wood L.D., Parsons D.W., Lin J., Barber T.D.,
RA   Mandelker D., Leary R.J., Ptak J., Silliman N., Szabo S.,
RA   Buckhaults P., Farrell C., Meeh P., Markowitz S.D., Willis J.,
RA   Dawson D., Willson J.K.V., Gazdar A.F., Hartigan J., Wu L., Liu C.,
RA   Parmigiani G., Park B.H., Bachman K.E., Papadopoulos N.,
RA   Vogelstein B., Kinzler K.W., Velculescu V.E.;
RT   "The consensus coding sequences of human breast and colorectal
RT   cancers.";
RL   Science 314:268-274(2006).
CC   -!- FUNCTION: Catalytic subunit of AMP-activated protein kinase
CC       (AMPK), an energy sensor protein kinase that plays a key role in
CC       regulating cellular energy metabolism. In response to reduction of
CC       intracellular ATP levels, AMPK activates energy-producing pathways
CC       and inhibits energy-consuming processes: inhibits protein,
CC       carbohydrate and lipid biosynthesis, as well as cell growth and
CC       proliferation. AMPK acts via direct phosphorylation of metabolic
CC       enzymes, and by longer-term effects via phosphorylation of
CC       transcription regulators. Also acts as a regulator of cellular
CC       polarity by remodeling the actin cytoskeleton; probably by
CC       indirectly activating myosin. Regulates lipid synthesis by
CC       phosphorylating and inactivating lipid metabolic enzymes such as
CC       ACACA, ACACB, GYS1, HMGCR and LIPE; regulates fatty acid and
CC       cholesterol synthesis by phosphorylating acetyl-CoA carboxylase
CC       (ACACA and ACACB) and hormone-sensitive lipase (LIPE) enzymes,
CC       respectively. Regulates insulin-signaling and glycolysis by
CC       phosphorylating IRS1, PFKFB2 and PFKFB3. AMPK stimulates glucose
CC       uptake in muscle by increasing the translocation of the glucose
CC       transporter SLC2A4/GLUT4 to the plasma membrane, possibly by
CC       mediating phosphorylation of TBC1D4/AS160. Regulates transcription
CC       and chromatin structure by phosphorylating transcription
CC       regulators involved in energy metabolism such as CRTC2/TORC2,
CC       FOXO3, histone H2B, HDAC5, MEF2C, MLXIPL/ChREBP, EP300, HNF4A,
CC       p53/TP53, SREBF1, SREBF2 and PPARGC1A. Acts as a key regulator of
CC       glucose homeostasis in liver by phosphorylating CRTC2/TORC2,
CC       leading to CRTC2/TORC2 sequestration in the cytoplasm. In response
CC       to stress, phosphorylates 'Ser-36' of histone H2B (H2BS36ph),
CC       leading to promote transcription. Acts as a key regulator of cell
CC       growth and proliferation by phosphorylating TSC2, RPTOR and
CC       ATG1/ULK1: in response to nutrient limitation, negatively
CC       regulates the mTORC1 complex by phosphorylating RPTOR component of
CC       the mTORC1 complex and by phosphorylating and activating TSC2. In
CC       response to nutrient limitation, promotes autophagy by
CC       phosphorylating and activating ATG1/ULK1. AMPK also acts as a
CC       regulator of circadian rhythm by mediating phosphorylation of
CC       CRY1, leading to destabilize it. May regulate the Wnt signaling
CC       pathway by phosphorylating CTNNB1, leading to stabilize it. Also
CC       has tau-protein kinase activity: in response to amyloid beta A4
CC       protein (APP) exposure, activated by CAMKK2, leading to
CC       phosphorylation of MAPT/TAU; however the relevance of such data
CC       remains unclear in vivo. Also phosphorylates CFTR, EEF2K, KLC1,
CC       NOS3 and SLC12A1. {ECO:0000269|PubMed:11518699,
CC       ECO:0000269|PubMed:11554766, ECO:0000269|PubMed:12519745,
CC       ECO:0000269|PubMed:14651849, ECO:0000269|PubMed:15866171,
CC       ECO:0000269|PubMed:17486097, ECO:0000269|PubMed:17711846,
CC       ECO:0000269|PubMed:18184930, ECO:0000269|PubMed:18439900,
CC       ECO:0000269|PubMed:20074060, ECO:0000269|PubMed:20160076,
CC       ECO:0000269|PubMed:21205641}.
CC   -!- CATALYTIC ACTIVITY: ATP + a protein = ADP + a phosphoprotein.
CC       {ECO:0000250|UniProtKB:P54645}.
CC   -!- CATALYTIC ACTIVITY: ATP + [acetyl-CoA carboxylase] = ADP +
CC       [acetyl-CoA carboxylase] phosphate.
CC       {ECO:0000250|UniProtKB:P54645}.
CC   -!- CATALYTIC ACTIVITY: ATP + [hydroxymethylglutaryl-CoA reductase
CC       (NADPH)] = ADP + [hydroxymethylglutaryl-CoA reductase (NADPH)]
CC       phosphate. {ECO:0000250|UniProtKB:P54645}.
CC   -!- CATALYTIC ACTIVITY: ATP + [tau protein] = ADP + [tau protein]
CC       phosphate.
CC   -!- COFACTOR:
CC       Name=Mg(2+); Xref=ChEBI:CHEBI:18420;
CC   -!- ENZYME REGULATION: Activated by phosphorylation on Thr-183.
CC       Binding of AMP to non-catalytic gamma subunit (PRKAG1, PRKAG2 or
CC       PRKAG3) results in allosteric activation, inducing phosphorylation
CC       on Thr-183. AMP-binding to gamma subunit also sustains activity by
CC       preventing dephosphorylation of Thr-183. ADP also stimulates Thr-
CC       183 phosphorylation, without stimulating already phosphorylated
CC       AMPK. ATP promotes dephosphorylation of Thr-183, rendering the
CC       enzyme inactive. Under physiological conditions AMPK mainly exists
CC       in its inactive form in complex with ATP, which is much more
CC       abundant than AMP. AMPK is activated by antihyperglycemic drug
CC       metformin, a drug prescribed to patients with type 2 diabetes: in
CC       vivo, metformin seems to mainly inhibit liver gluconeogenesis.
CC       However, metformin can be used to activate AMPK in muscle and
CC       other cells in culture or ex vivo (PubMed:11602624). Selectively
CC       inhibited by compound C (6-[4-(2-Piperidin-1-yl-ethoxy)-phenyl)]-
CC       3-pyridin-4-yl-pyyrazolo[1,5-a] pyrimidine. Activated by
CC       resveratrol, a natural polyphenol present in red wine, and S17834,
CC       a synthetic polyphenol. {ECO:0000269|PubMed:11602624,
CC       ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15980064,
CC       ECO:0000269|PubMed:16054095, ECO:0000269|PubMed:21680840}.
CC   -!- SUBUNIT: AMPK is a heterotrimer of an alpha catalytic subunit
CC       (PRKAA1 or PRKAA2), a beta (PRKAB1 or PRKAB2) and a gamma non-
CC       catalytic subunits (PRKAG1, PRKAG2 or PRKAG3). Interacts with
CC       FNIP1 and FNIP2. {ECO:0000269|PubMed:17028174,
CC       ECO:0000269|PubMed:18403135, ECO:0000269|PubMed:18663353,
CC       ECO:0000269|PubMed:21680840}.
CC   -!- INTERACTION:
CC       Q9NYB9:ABI2; NbExp=3; IntAct=EBI-1181405, EBI-743598;
CC       Q08117:AES; NbExp=3; IntAct=EBI-1181405, EBI-717810;
CC       O14503:BHLHE40; NbExp=3; IntAct=EBI-1181405, EBI-711810;
CC       O14627:CDX4; NbExp=3; IntAct=EBI-1181405, EBI-10181162;
CC       Q13363-2:CTBP1; NbExp=3; IntAct=EBI-1181405, EBI-10171858;
CC       O95073:FSBP; NbExp=3; IntAct=EBI-1181405, EBI-1059030;
CC       Q08379:GOLGA2; NbExp=3; IntAct=EBI-1181405, EBI-618309;
CC       Q6NT76:HMBOX1; NbExp=3; IntAct=EBI-1181405, EBI-2549423;
CC       Q8IX15-3:HOMEZ; NbExp=3; IntAct=EBI-1181405, EBI-10172004;
CC       P08238:HSP90AB1; NbExp=2; IntAct=EBI-1181405, EBI-352572;
CC       Q9UKT9:IKZF3; NbExp=3; IntAct=EBI-1181405, EBI-747204;
CC       Q8NBZ0:INO80E; NbExp=3; IntAct=EBI-1181405, EBI-769401;
CC       Q6A162:KRT40; NbExp=3; IntAct=EBI-1181405, EBI-10171697;
CC       Q96JM7:L3MBTL3; NbExp=3; IntAct=EBI-1181405, EBI-2686809;
CC       Q5JR59:MTUS2; NbExp=3; IntAct=EBI-1181405, EBI-742948;
CC       Q8IXK0:PHC2; NbExp=3; IntAct=EBI-1181405, EBI-713786;
CC       Q96PV4:PNMA5; NbExp=3; IntAct=EBI-1181405, EBI-10171633;
CC       Q9Y478:PRKAB1; NbExp=6; IntAct=EBI-1181405, EBI-719769;
CC       O43741:PRKAB2; NbExp=12; IntAct=EBI-1181405, EBI-1053424;
CC       P54619:PRKAG1; NbExp=10; IntAct=EBI-1181405, EBI-1181439;
CC       Q93062:RBPMS; NbExp=3; IntAct=EBI-1181405, EBI-740322;
CC       Q8HWS3:RFX6; NbExp=3; IntAct=EBI-1181405, EBI-746118;
CC       Q9UFD9:RIMBP3; NbExp=3; IntAct=EBI-1181405, EBI-10182375;
CC       Q9HAT0:ROPN1; NbExp=3; IntAct=EBI-1181405, EBI-1378139;
CC       Q9Y2D8:SSX2IP; NbExp=3; IntAct=EBI-1181405, EBI-2212028;
CC       Q9NVV9:THAP1; NbExp=3; IntAct=EBI-1181405, EBI-741515;
CC       P14373:TRIM27; NbExp=3; IntAct=EBI-1181405, EBI-719493;
CC       Q15654:TRIP6; NbExp=3; IntAct=EBI-1181405, EBI-742327;
CC       Q9Y3Q8:TSC22D4; NbExp=3; IntAct=EBI-1181405, EBI-739485;
CC       Q5T124:UBXN11; NbExp=3; IntAct=EBI-1181405, EBI-746004;
CC       Q9H9H4:VPS37B; NbExp=3; IntAct=EBI-1181405, EBI-4400866;
CC       Q8N1B4:VPS52; NbExp=3; IntAct=EBI-1181405, EBI-2799833;
CC       O96006:ZBED1; NbExp=3; IntAct=EBI-1181405, EBI-740037;
CC   -!- SUBCELLULAR LOCATION: Cytoplasm {ECO:0000269|PubMed:15866171}.
CC       Nucleus {ECO:0000269|PubMed:15866171}. Note=In response to stress,
CC       recruited by p53/TP53 to specific promoters.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q13131-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q13131-2; Sequence=VSP_035431;
CC   -!- DOMAIN: The AIS (autoinhibitory sequence) region shows some
CC       sequence similarity with the ubiquitin-associated domains and
CC       represses kinase activity. {ECO:0000269|PubMed:17088252,
CC       ECO:0000269|PubMed:9857077}.
CC   -!- PTM: Ubiquitinated. {ECO:0000250}.
CC   -!- PTM: Phosphorylated at Thr-183 by STK11/LKB1 in complex with
CC       STE20-related adapter-alpha (STRADA) pseudo kinase and CAB39. Also
CC       phosphorylated at Thr-183 by CAMKK2; triggered by a rise in
CC       intracellular calcium ions, without detectable changes in the
CC       AMP/ATP ratio. CAMKK1 can also phosphorylate Thr-183, but at a
CC       much lower level. Dephosphorylated by protein phosphatase 2A and
CC       2C (PP2A and PP2C). Phosphorylated by ULK1 and ULK2; leading to
CC       negatively regulate AMPK activity and suggesting the existence of
CC       a regulatory feedback loop between ULK1, ULK2 and AMPK.
CC       Dephosphorylated by PPM1A and PPM1B. {ECO:0000269|PubMed:14976552,
CC       ECO:0000269|PubMed:15980064, ECO:0000269|PubMed:16054095,
CC       ECO:0000269|PubMed:21460634}.
CC   -!- SIMILARITY: Belongs to the protein kinase superfamily. CAMK
CC       Ser/Thr protein kinase family. SNF1 subfamily. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAA64850.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAD43027.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=AAH37303.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAA36547.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC       Sequence=BAG35788.1; Type=Erroneous initiation; Note=Translation N-terminally extended.; Evidence={ECO:0000305};
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AC008810; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC048980; AAH48980.1; -; mRNA.
DR   EMBL; AB022017; BAA36547.1; ALT_INIT; mRNA.
DR   EMBL; AK312947; BAG35788.1; ALT_INIT; mRNA.
DR   EMBL; BC037303; AAH37303.1; ALT_INIT; mRNA.
DR   EMBL; AF100763; AAD43027.1; ALT_INIT; mRNA.
DR   EMBL; U22456; AAA64850.1; ALT_INIT; mRNA.
DR   EMBL; Y12856; CAA73361.1; -; mRNA.
DR   CCDS; CCDS3932.2; -. [Q13131-1]
DR   CCDS; CCDS3933.2; -. [Q13131-2]
DR   PIR; G01743; G01743.
DR   RefSeq; NP_006242.5; NM_006251.5. [Q13131-1]
DR   RefSeq; NP_996790.3; NM_206907.3. [Q13131-2]
DR   UniGene; Hs.43322; -.
DR   PDB; 4RED; X-ray; 2.95 A; A/B=22-362.
DR   PDB; 4RER; X-ray; 4.05 A; A=20-559.
DR   PDB; 4REW; X-ray; 4.58 A; A=20-559.
DR   PDB; 5EZV; X-ray; 2.99 A; A/C=359-401.
DR   PDBsum; 4RED; -.
DR   PDBsum; 4RER; -.
DR   PDBsum; 4REW; -.
DR   PDBsum; 5EZV; -.
DR   ProteinModelPortal; Q13131; -.
DR   SMR; Q13131; -.
DR   BioGrid; 111549; 150.
DR   DIP; DIP-39973N; -.
DR   IntAct; Q13131; 99.
DR   MINT; MINT-6771251; -.
DR   STRING; 9606.ENSP00000346148; -.
DR   BindingDB; Q13131; -.
DR   ChEMBL; CHEMBL4045; -.
DR   DrugBank; DB00945; Acetylsalicylic acid.
DR   DrugBank; DB00131; Adenosine monophosphate.
DR   DrugBank; DB00171; Adenosine triphosphate.
DR   DrugBank; DB00914; Phenformin.
DR   GuidetoPHARMACOLOGY; 1541; -.
DR   iPTMnet; Q13131; -.
DR   PhosphoSitePlus; Q13131; -.
DR   BioMuta; PRKAA1; -.
DR   DMDM; 254763436; -.
DR   EPD; Q13131; -.
DR   MaxQB; Q13131; -.
DR   PaxDb; Q13131; -.
DR   PeptideAtlas; Q13131; -.
DR   PRIDE; Q13131; -.
DR   DNASU; 5562; -.
DR   Ensembl; ENST00000354209; ENSP00000346148; ENSG00000132356. [Q13131-2]
DR   Ensembl; ENST00000397128; ENSP00000380317; ENSG00000132356. [Q13131-1]
DR   GeneID; 5562; -.
DR   KEGG; hsa:5562; -.
DR   UCSC; uc003jmb.4; human. [Q13131-1]
DR   CTD; 5562; -.
DR   DisGeNET; 5562; -.
DR   GeneCards; PRKAA1; -.
DR   H-InvDB; HIX0004832; -.
DR   HGNC; HGNC:9376; PRKAA1.
DR   HPA; CAB005050; -.
DR   HPA; HPA035409; -.
DR   HPA; HPA064946; -.
DR   MIM; 602739; gene.
DR   neXtProt; NX_Q13131; -.
DR   OpenTargets; ENSG00000132356; -.
DR   PharmGKB; PA33744; -.
DR   eggNOG; KOG0586; Eukaryota.
DR   eggNOG; ENOG410XNQ0; LUCA.
DR   GeneTree; ENSGT00870000136390; -.
DR   HOGENOM; HOG000233016; -.
DR   HOVERGEN; HBG050432; -.
DR   KO; K07198; -.
DR   OMA; NYRSCQK; -.
DR   OrthoDB; EOG091G03TG; -.
DR   PhylomeDB; Q13131; -.
DR   TreeFam; TF314032; -.
DR   BRENDA; 2.7.11.1; 2681.
DR   Reactome; R-HSA-1632852; Macroautophagy.
DR   Reactome; R-HSA-380972; Energy dependent regulation of mTOR by LKB1-AMPK.
DR   Reactome; R-HSA-5628897; TP53 Regulates Metabolic Genes.
DR   Reactome; R-HSA-6804756; Regulation of TP53 Activity through Phosphorylation.
DR   SignaLink; Q13131; -.
DR   SIGNOR; Q13131; -.
DR   ChiTaRS; PRKAA1; human.
DR   GeneWiki; Protein_kinase,_AMP-activated,_alpha_1; -.
DR   GenomeRNAi; 5562; -.
DR   PRO; PR:Q13131; -.
DR   Proteomes; UP000005640; Chromosome 5.
DR   Bgee; ENSG00000132356; -.
DR   CleanEx; HS_PRKAA1; -.
DR   ExpressionAtlas; Q13131; baseline and differential.
DR   Genevisible; Q13131; HS.
DR   GO; GO:0016324; C:apical plasma membrane; IEA:Ensembl.
DR   GO; GO:0005737; C:cytoplasm; IBA:GO_Central.
DR   GO; GO:0005829; C:cytosol; IDA:HPA.
DR   GO; GO:0005622; C:intracellular; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0016607; C:nuclear speck; IDA:HPA.
DR   GO; GO:0005654; C:nucleoplasm; TAS:Reactome.
DR   GO; GO:0031588; C:nucleotide-activated protein kinase complex; ISS:UniProtKB.
DR   GO; GO:0005634; C:nucleus; ISS:UniProtKB.
DR   GO; GO:0050405; F:[acetyl-CoA carboxylase] kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0047322; F:[hydroxymethylglutaryl-CoA reductase (NADPH)] kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0004679; F:AMP-activated protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0004691; F:cAMP-dependent protein kinase activity; NAS:UniProtKB.
DR   GO; GO:0003682; F:chromatin binding; ISS:UniProtKB.
DR   GO; GO:0035174; F:histone serine kinase activity; ISS:UniProtKB.
DR   GO; GO:0019900; F:kinase binding; IEA:Ensembl.
DR   GO; GO:0046872; F:metal ion binding; IEA:UniProtKB-KW.
DR   GO; GO:0008022; F:protein C-terminus binding; IEA:Ensembl.
DR   GO; GO:0004672; F:protein kinase activity; IDA:UniProtKB.
DR   GO; GO:0050321; F:tau-protein kinase activity; IEA:UniProtKB-EC.
DR   GO; GO:0000187; P:activation of MAPK activity; NAS:UniProtKB.
DR   GO; GO:0061762; P:CAMKK-AMPK signaling cascade; IMP:ParkinsonsUK-UCL.
DR   GO; GO:0007050; P:cell cycle arrest; TAS:Reactome.
DR   GO; GO:0071361; P:cellular response to ethanol; IEA:Ensembl.
DR   GO; GO:0042149; P:cellular response to glucose starvation; ISS:UniProtKB.
DR   GO; GO:0070301; P:cellular response to hydrogen peroxide; IEA:Ensembl.
DR   GO; GO:0071456; P:cellular response to hypoxia; IEA:Ensembl.
DR   GO; GO:0031669; P:cellular response to nutrient levels; ISS:UniProtKB.
DR   GO; GO:0071417; P:cellular response to organonitrogen compound; IEA:Ensembl.
DR   GO; GO:0071380; P:cellular response to prostaglandin E stimulus; IEA:Ensembl.
DR   GO; GO:0006695; P:cholesterol biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0009631; P:cold acclimation; IEA:Ensembl.
DR   GO; GO:0006633; P:fatty acid biosynthetic process; IEA:UniProtKB-KW.
DR   GO; GO:0055089; P:fatty acid homeostasis; ISS:UniProtKB.
DR   GO; GO:0019395; P:fatty acid oxidation; IEA:Ensembl.
DR   GO; GO:0042593; P:glucose homeostasis; ISS:UniProtKB.
DR   GO; GO:0006006; P:glucose metabolic process; IEA:Ensembl.
DR   GO; GO:0035556; P:intracellular signal transduction; IBA:GO_Central.
DR   GO; GO:0008610; P:lipid biosynthetic process; ISS:UniProtKB.
DR   GO; GO:0016236; P:macroautophagy; TAS:Reactome.
DR   GO; GO:0043066; P:negative regulation of apoptotic process; ISS:UniProtKB.
DR   GO; GO:2001274; P:negative regulation of glucose import in response to insulin stimulus; IEA:Ensembl.
DR   GO; GO:0046318; P:negative regulation of glucosylceramide biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0050995; P:negative regulation of lipid catabolic process; ISS:UniProtKB.
DR   GO; GO:0032007; P:negative regulation of TOR signaling; ISS:UniProtKB.
DR   GO; GO:0010508; P:positive regulation of autophagy; IDA:ParkinsonsUK-UCL.
DR   GO; GO:0008284; P:positive regulation of cell proliferation; IEA:Ensembl.
DR   GO; GO:0045542; P:positive regulation of cholesterol biosynthetic process; NAS:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IDA:UniProtKB.
DR   GO; GO:0045821; P:positive regulation of glycolytic process; ISS:UniProtKB.
DR   GO; GO:0048643; P:positive regulation of skeletal muscle tissue development; IEA:Ensembl.
DR   GO; GO:0051291; P:protein heterooligomerization; IEA:Ensembl.
DR   GO; GO:0006468; P:protein phosphorylation; IDA:UniProtKB.
DR   GO; GO:0042752; P:regulation of circadian rhythm; ISS:UniProtKB.
DR   GO; GO:2000505; P:regulation of energy homeostasis; ISS:UniProtKB.
DR   GO; GO:0033135; P:regulation of peptidyl-serine phosphorylation; IEA:Ensembl.
DR   GO; GO:1901796; P:regulation of signal transduction by p53 class mediator; TAS:Reactome.
DR   GO; GO:0006355; P:regulation of transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0060627; P:regulation of vesicle-mediated transport; IEA:Ensembl.
DR   GO; GO:0014823; P:response to activity; IEA:Ensembl.
DR   GO; GO:0031000; P:response to caffeine; IEA:Ensembl.
DR   GO; GO:1901563; P:response to camptothecin; IEA:Ensembl.
DR   GO; GO:0010332; P:response to gamma radiation; ISS:UniProtKB.
DR   GO; GO:0001666; P:response to hypoxia; NAS:UniProtKB.
DR   GO; GO:0009411; P:response to UV; IEA:Ensembl.
DR   GO; GO:0048511; P:rhythmic process; IEA:UniProtKB-KW.
DR   GO; GO:0007165; P:signal transduction; TAS:ProtInc.
DR   GO; GO:0006351; P:transcription, DNA-templated; IEA:UniProtKB-KW.
DR   GO; GO:0016055; P:Wnt signaling pathway; IEA:UniProtKB-KW.
DR   InterPro; IPR032270; AMPK_C.
DR   InterPro; IPR028375; KA1/Ssp2_C.
DR   InterPro; IPR011009; Kinase-like_dom.
DR   InterPro; IPR000719; Prot_kinase_dom.
DR   InterPro; IPR017441; Protein_kinase_ATP_BS.
DR   InterPro; IPR008271; Ser/Thr_kinase_AS.
DR   Pfam; PF16579; AdenylateSensor; 1.
DR   Pfam; PF00069; Pkinase; 1.
DR   SMART; SM00220; S_TKc; 1.
DR   SUPFAM; SSF103243; SSF103243; 1.
DR   SUPFAM; SSF56112; SSF56112; 1.
DR   PROSITE; PS00107; PROTEIN_KINASE_ATP; 1.
DR   PROSITE; PS50011; PROTEIN_KINASE_DOM; 1.
DR   PROSITE; PS00108; PROTEIN_KINASE_ST; 1.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; ATP-binding; Autophagy;
KW   Biological rhythms; Cholesterol biosynthesis; Cholesterol metabolism;
KW   Chromatin regulator; Complete proteome; Cytoplasm;
KW   Fatty acid biosynthesis; Fatty acid metabolism; Kinase;
KW   Lipid biosynthesis; Lipid metabolism; Magnesium; Metal-binding;
KW   Nucleotide-binding; Nucleus; Phosphoprotein; Polymorphism;
KW   Reference proteome; Serine/threonine-protein kinase;
KW   Steroid biosynthesis; Steroid metabolism; Sterol biosynthesis;
KW   Sterol metabolism; Transcription; Transcription regulation;
KW   Transferase; Ubl conjugation; Wnt signaling pathway.
FT   CHAIN         1    559       5'-AMP-activated protein kinase catalytic
FT                                subunit alpha-1.
FT                                /FTId=PRO_0000085589.
FT   DOMAIN       27    279       Protein kinase. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   NP_BIND      33     41       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   REGION      302    381       AIS.
FT   ACT_SITE    150    150       Proton acceptor. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159, ECO:0000255|PROSITE-
FT                                ProRule:PRU10027}.
FT   BINDING      56     56       ATP. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00159}.
FT   MOD_RES      32     32       Phosphothreonine.
FT                                {ECO:0000244|PubMed:19369195,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     183    183       Phosphothreonine; by LKB1 and CaMKK2.
FT                                {ECO:0000250}.
FT   MOD_RES     269    269       Phosphothreonine.
FT                                {ECO:0000250|UniProtKB:P54645}.
FT   MOD_RES     355    355       Phosphothreonine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     356    356       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648}.
FT   MOD_RES     360    360       Phosphoserine; by ULK1. {ECO:0000250}.
FT   MOD_RES     368    368       Phosphothreonine; by ULK1. {ECO:0000250}.
FT   MOD_RES     382    382       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18220336,
FT                                ECO:0000244|PubMed:19690332,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     397    397       Phosphoserine; by ULK1.
FT                                {ECO:0000305|PubMed:21460634}.
FT   MOD_RES     467    467       Phosphoserine.
FT                                {ECO:0000244|PubMed:19369195}.
FT   MOD_RES     486    486       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     488    488       Phosphothreonine; by ULK1.
FT                                {ECO:0000305|PubMed:21460634}.
FT   MOD_RES     490    490       Phosphothreonine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163}.
FT   MOD_RES     496    496       Phosphoserine.
FT                                {ECO:0000244|PubMed:18669648,
FT                                ECO:0000244|PubMed:23186163,
FT                                ECO:0000244|PubMed:24275569}.
FT   MOD_RES     508    508       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     524    524       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   MOD_RES     527    527       Phosphoserine.
FT                                {ECO:0000244|PubMed:24275569}.
FT   VAR_SEQ     121    121       R -> RKSDVPGVVKTGSTKE (in isoform 2).
FT                                {ECO:0000303|PubMed:15489334}.
FT                                /FTId=VSP_035431.
FT   VARIANT      10     10       M -> L (in dbSNP:rs17855679).
FT                                {ECO:0000269|PubMed:15489334}.
FT                                /FTId=VAR_058401.
FT   VARIANT      16     16       Q -> R (in a breast cancer sample;
FT                                somatic mutation).
FT                                {ECO:0000269|PubMed:16959974}.
FT                                /FTId=VAR_035622.
FT   MUTAGEN     307    307       V->G,Q: Activates the kinase activity.
FT                                {ECO:0000269|PubMed:17088252}.
FT   CONFLICT      5      5       S -> C (in Ref. 4; BAG35788).
FT                                {ECO:0000305}.
FT   CONFLICT      9      9       K -> S (in Ref. 5; AAD43027).
FT                                {ECO:0000305}.
FT   CONFLICT     37     37       T -> A (in Ref. 6; AAA64850).
FT                                {ECO:0000305}.
FT   CONFLICT    202    202       A -> V (in Ref. 6; AAA64850).
FT                                {ECO:0000305}.
FT   CONFLICT    208    208       I -> L (in Ref. 6; AAA64850).
FT                                {ECO:0000305}.
FT   CONFLICT    269    269       T -> S (in Ref. 3; BAA36547).
FT                                {ECO:0000305}.
FT   STRAND       27     35       {ECO:0000244|PDB:4RED}.
FT   STRAND       40     49       {ECO:0000244|PDB:4RED}.
FT   STRAND       52     59       {ECO:0000244|PDB:4RED}.
FT   HELIX        60     66       {ECO:0000244|PDB:4RED}.
FT   STRAND       68     70       {ECO:0000244|PDB:4RED}.
FT   HELIX        71     77       {ECO:0000244|PDB:4RED}.
FT   STRAND       90     95       {ECO:0000244|PDB:4RED}.
FT   STRAND       97    105       {ECO:0000244|PDB:4RED}.
FT   HELIX       112    118       {ECO:0000244|PDB:4RED}.
FT   HELIX       124    144       {ECO:0000244|PDB:4RED}.
FT   HELIX       153    155       {ECO:0000244|PDB:4RED}.
FT   STRAND      156    158       {ECO:0000244|PDB:4RED}.
FT   STRAND      164    167       {ECO:0000244|PDB:4RED}.
FT   STRAND      169    171       {ECO:0000244|PDB:4RED}.
FT   HELIX       193    196       {ECO:0000244|PDB:4RED}.
FT   HELIX       204    220       {ECO:0000244|PDB:4RED}.
FT   STRAND      227    229       {ECO:0000244|PDB:4RED}.
FT   HELIX       231    233       {ECO:0000244|PDB:4RED}.
FT   HELIX       250    259       {ECO:0000244|PDB:4RED}.
FT   HELIX       264    266       {ECO:0000244|PDB:4RED}.
FT   HELIX       270    274       {ECO:0000244|PDB:4RED}.
FT   HELIX       277    280       {ECO:0000244|PDB:4RED}.
FT   TURN        296    298       {ECO:0000244|PDB:4RED}.
FT   HELIX       301    310       {ECO:0000244|PDB:4RED}.
FT   HELIX       315    323       {ECO:0000244|PDB:4RED}.
FT   HELIX       330    340       {ECO:0000244|PDB:4RED}.
FT   TURN        347    351       {ECO:0000244|PDB:4RED}.
FT   HELIX       372    374       {ECO:0000244|PDB:5EZV}.
SQ   SEQUENCE   559 AA;  64009 MW;  ABAE71FBF912947A CRC64;
     MRRLSSWRKM ATAEKQKHDG RVKIGHYILG DTLGVGTFGK VKVGKHELTG HKVAVKILNR
     QKIRSLDVVG KIRREIQNLK LFRHPHIIKL YQVISTPSDI FMVMEYVSGG ELFDYICKNG
     RLDEKESRRL FQQILSGVDY CHRHMVVHRD LKPENVLLDA HMNAKIADFG LSNMMSDGEF
     LRTSCGSPNY AAPEVISGRL YAGPEVDIWS SGVILYALLC GTLPFDDDHV PTLFKKICDG
     IFYTPQYLNP SVISLLKHML QVDPMKRATI KDIREHEWFK QDLPKYLFPE DPSYSSTMID
     DEALKEVCEK FECSEEEVLS CLYNRNHQDP LAVAYHLIID NRRIMNEAKD FYLATSPPDS
     FLDDHHLTRP HPERVPFLVA ETPRARHTLD ELNPQKSKHQ GVRKAKWHLG IRSQSRPNDI
     MAEVCRAIKQ LDYEWKVVNP YYLRVRRKNP VTSTYSKMSL QLYQVDSRTY LLDFRSIDDE
     ITEAKSGTAT PQRSGSVSNY RSCQRSDSDA EAQGKSSEVS LTSSVTSLDS SPVDLTPRPG
     SHTIEFFEMC ANLIKILAQ
//
